Navigation Links
Improving The Survival Of Lung Cancer Patients By Blocking The Effects Of Estrogen

Stopping or slowing the spread of lung cancer may depend on the addition of drugs that block the effects of estrogen, // say researchers according to a recent study .

For the study researchers evaluated the effects of three different treatments that block the action of estrogen in human lung tumors grafted in mice. They studied the effectiveness of an estrogen receptor-blocking drug (fulvestrant, also known as Faslodex), an epidermal growth factor receptor-blocking drug (gefitinib, also known as Iressa), and a combination of both drugs.

Results showed combining both drugs was most effective at shrinking the tumors, with a 59-percent decrease in tumor volume compared to a 49-percent decrease using gefitinib alone and a 32-percent decrease using fulvestrant alone.

In another study done researchers found estrogen regulated some of the same growth genes in lung cancer as in breast cancer and results showed that the same estrogen inhibitor from the first study, fulvestrant, also blocked estrogen's ability to regulate lung cancer cell gene expression.

Thus researchers say both of these studies clearly suggest that lung cancer cells respond to estrogen and that improving overall patient survival may be contingent upon identifying therapies that target specific pathways and put a halt to estrogen signaling.
'"/>




Page: 1

Related medicine news :

1. Plastic Sling Has Proved Successful In Improving Aging Of The Neck
2. Improving Survival Rate Of Lung Cancer Patients
3. Combination Therapy Effective In Improving Lung Cancer Survival
4. Improving Life Expectancy
5. Improving Fertility In Patients With Cervical Cancer
6. Improving Lighting Could Bring About A Change In Alzheimers Patients
7. Device For Improving Bone Mass In Osteoporosis
8. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
9. US To Look In To Improving the Elder Care
10. Saw Palmetto Extract No Good In Improving Prostate Health
11. Rahul Mahajans Condition Improving; Vital Parametres Normal
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a leading provider ... magazine has named the company a “Top 25 Cybersecurity Companies 2017.” Axiad ... help organizations simply and proactively address potential cybersecurity threats before they happen. The ...
(Date:5/23/2017)... ... 23, 2017 , ... PM360, the premier information resource for ... winners of its 3rd Annual ELITE Awards. The ELITE (Exceptional • Leaders • ... industry today. , Out of more than 500 submissions, 100 winners were selected ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of ... Worthy of a Policy Response”, -The Rory Staunton Foundation Calls on Health & Human ... the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a new study released ...
(Date:5/23/2017)... ... 23, 2017 , ... The National Council on Strength and ... the organization’s Certified Strength Coach credential has earned accreditation from the National Commission ... the competency of qualified candidates for jobs in the Strength and Conditioning profession. ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment option called ... elastin in their face, neck, and body through a virtually pain-free, non-surgical treatment. ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017  Demonstrating its commitment ... of directors for the Pharmaceutical Research and Manufacturers ... membership. Biopharmaceutical companies will now have to meet ... to be eligible to join PhRMA. ... board is sending a clear message that being ...
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
Breaking Medicine Technology: